For purposes of this division, the following definitions apply: (a) âDonorâ means an individual who donates unused prescription drugs to a participating practitioner for the purpose of redistribution to established patients of that practitioner. (b) âIneligible drugsâ means drugs that are not able to be accepted for redistribution as part of the program established pursuant to this division. âIneligible drugsâ include all controlled substances, including all opioids, all compounded medications, injectable medications, drugs that have an approved United States Food and Drug Administration Risk Evaluation and Mitigation Strategy (REMS) requirement, and all growth factor medications. (c) âParticipating practitionerâ means a person who is licensed to practice medicine by the Medical Board of California and is board certified in medical oncology or hematology and is registered with a surplus medication collection and distribution intermediary. (d) âRecipientâ means an individual who voluntarily receives donated prescription medications. (e) âSurplus medication collection and distribution intermediaryâ means an entity licensed pursuant to Section 4169.5 of the Business and Professions Code as a surplus medication collection and distribution intermediary, as described in Section 150208. (f) âUnused cancer medicationâ or âmedicationâ means a medication or drug, including a âdangerous drugâ as defined in Section 4022 of the Business and Professions Code or a âdrugâ as defined in Section 4025 of the Business and Professions Code, that is prescribed as part of a cancer treatment plan and is in its original container or packaging.
‹ Prev All California sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.